References
- RabeKFHurdSAnzuetoAGlobal Initiative for Chronic Obstructive Lung DiseaseGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2007176653255517507545
- WedzichaJASeemungalTACOPD exacerbations: defining their cause and preventionLancet2007370958978679617765528
- DonaldsonGCSeemungalTABhowmikAWedzichaJARelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax2002571084785212324669
- KannerREAnthonisenNRConnettJELung Health Study Research GroupLower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health studyAm J Respir Crit Care Med2001164335836411500333
- SeemungalTADonaldsonGCPaulEABestallJCJeffriesDJWedzichaJAEffect of exacerbation on quality of life in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19981575 Pt 1141814229603117
- MiravitllesMFerrerMPontAIMPAC Study GroupEffect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up studyThorax200459538739515115864
- Soler-CataluñaJJMartínez-GarcíaMARomán SánchezPSalcedoENavarroMOchandoRSevere acute exacerbations and mortality in patients with chronic obstructive pulmonary diseaseThorax2005601192593116055622
- ConnorsAFJrDawsonNVThomasCOutcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments)Am J Respir Crit Care Med19961544 Pt 19599678887592
- SullivanSDRamseySDLeeTAThe economic burden of COPDChest20001172(suppl)5S9S10673466
- BrittonMThe burden of COPD in the UK: results from the Confronting COPD surveyRespir Med200397suppl CS71S7912647945
- Rodriguez-RoisinRToward a consensus definition for COPD exacerbationsChest20001175(suppl 2)398S401S10843984
- AgustíASolerJJMolinaJIs the CAT questionnaire sensitive to changes in health status in patients with severe COPD exacerbations?COPD20129549249822958111
- JonesPWHardingGBerryPWiklundIChenWHKline LeidyNDevelopment and first validation of the COPD Assessment TestEur Respir J200934364865419720809
- JonesPWBrusselleGDal NegroRWProperties of the COPD assessment test in a cross-sectional European studyEur Respir J2011381293521565915
- KellyJLBamseyOSmithCHealth status assessment in routine clinical practice: the chronic obstructive pulmonary disease assessment test score in outpatientsRespiration201284319319922441322
- BestallJCPaulEAGarrodRGarnhamRJonesPWWedzichaJAUsefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary diseaseThorax199954758158610377201
- MillerMRHankinsonJBrusascoVStandardisation of spirometryEur Respir J200526231933816055882
- Statement ATSATS Committee on Proficiency Standards for Clinical Pulmonary Function LaboratoriesATS statement: guidelines for the six-minute walk testAm J Respir Crit Care Med2002166111111712091180
- PothiratCPhetsukNDeesomchokAClinical characteristics, management in real world practice and long-term survival among COPD patients of Northern Thailand COPD club membersJ Med Assoc Thai200790465366217487118
- Feliz-RodriguezDZudaireSCarpioCEvolution of the COPD Assessment Test score during chronic obstructive pulmonary disease exacerbations: determinants and prognostic valueCan Respir J2013205e92e9724093119